While the government continues to spend billions of dollars on more drugs everyone hopes will never be used, it has yet to safeguard or account for the growing number of high-containment laboratories where those medical countermeasures (MCMs) are being developed, the Government Accountability Office (GAO) said in a new report that echoes an alarm the office first sounded three years ago.